Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells (Q39090075)

9 September 2017

Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells (English)

1 reference

9 September 2017

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077694%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Antonio González-Sarrías

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077694%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Juan A. Giménez-Bastida

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077694%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

María A Nuñez-Sánchez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077694%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Mar Larrosa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077694%20AND%20SRC:MED&resulttype=core&format=json

María-Teresa García-Conesa

31 May 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077694%20AND%20SRC:MED&resulttype=core&format=json

Francisco A Tomas-Barberan

31 May 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077694%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Antonio González-Sarrías

1

1 reference

9 September 2017

Juan Antonio Giménez-Bastida

2

1 reference

9 September 2017

María Ángeles Núñez-Sánchez

3

1 reference

9 September 2017

Mar Larrosa

4

1 reference

9 September 2017

María Teresa García-Conesa

5

1 reference

9 September 2017

Francisco A Tomás-Barberán

6

1 reference

9 September 2017

1 April 2014

1 reference

European Journal of Nutrition

9 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077694%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077694%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077694%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

853-864

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24077694%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00394-013-0589-4

31 May 2020

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Dietary polyphenolic phytochemicals--promising cancer chemopreventive agents in humans? A review of their clinical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Polyphenolic compounds in chemoprevention of colon cancer - targets and signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Identification of urolithin a as a metabolite produced by human colon microflora from ellagic acid and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Ellagitannins, ellagic acid and vascular health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

UV and MS identification of Urolithins and Nasutins, the bioavailable metabolites of ellagitannins and ellagic acid in different mammals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Strawberry processing does not affect the production and urinary excretion of urolithins, ellagic acid metabolites, in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Effects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, on Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Antiglycative and neuroprotective activity of colon-derived polyphenol catabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Intestinal ellagitannin metabolites ameliorate cytokine-induced inflammation and associated molecular markers in human colon fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Ellagitannins of the fruit rind of pomegranate (Punica granatum) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Urolithins, ellagitannin metabolites produced by colon microbiota, inhibit Quorum Sensing in Yersinia enterocolitica: Phenotypic response and associated molecular changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Intestinal and hepatic glucuronidation of flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase 3 cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Cancer chemotherapy and drug metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

The role of ABC transporters in drug resistance, metabolism and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

ABCG2 (breast cancer resistance protein/mitoxantrone resistance-associated protein) ATPase assay: a useful tool to detect drug-transporter interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

ABC transporters and their role in nucleoside and nucleotide drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

The grape and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Induction of UGT1A1 and CYP2B6 by an antimitogenic factor in HepG2 cells is mediated through suppression of cyclin-dependent kinase 2 activity: cell cycle-dependent expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-α-induced inflammation and associated molecular markers in human aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Bioavailability of the Glucuronide and Sulfate Conjugates of Genistein and Daidzein in Breast Cancer Resistance Protein 1 Knockout Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00394-013-0589-4

Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additives

21 January 2018

1 reference

12 December 2020

Tetrazolium (MTT) assay for cellular viability and activity.

1 reference

12 December 2020

Biological significance of urolithins, the gut microbial ellagic Acid-derived metabolites: the evidence so far

1 reference

12 December 2020

Extracts from Epilobium sp. herbs, their components and gut microbiota metabolites of Epilobium ellagitannins, urolithins, inhibit hormone-dependent prostate cancer cells-(LNCaP) proliferation and PSA secretion.

1 reference

12 December 2020

Effects of cell differentiation and assay conditions on the UDP-glucuronosyltransferase activity in Caco-2 cells

1 reference

12 December 2020